As you know, they also have a very active vaccine development programme and several of their vaccine candidates are in advanced stages of clinical trial, so this is also of interest to us, so we're following those very closely.
Kama mnavyofahamu,pia wanayo programu amilifu ya kukuza chanjo na baadhi ya chanjo yako hatua mbele katika majaribio ya kliniki, huu pia ni maslahi kwetu, tunaifuatilia kwa karibu.